Simon Webster looks at the role of intellectual property (IP) management in protecting pharmaceutical company products.
Haydn Evans
Advertisement
Haydn Evans is Vice President, IP Outsourcing, Eurpe, at CPA Global (UK).
Articles by Haydn Evans
Advertisement
Latest Updated Articles
The Need for Intelligent IP managementPublished: February 10th 2017 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
3
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
4
Is FDA Streamlining Regulations in the Biosimilar Space?
5
